Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,130 JPY | -0.19% | +1.47% | +1.87% |
16/05 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
15/05 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.87% | 4.18TCr | |
+32.27% | 69TCr | |
+29.39% | 59TCr | |
-1.56% | 37TCr | |
+20.00% | 33TCr | |
+7.16% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.67% | 17TCr |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Transcript : Takeda Pharmaceutical Company Limited, Q2 2015 Earnings Call, Oct 30, 2014